Kardigan Inc

Kardigan Inc (KARD) News & Events

$13.510

+0.594 (+4.40%)At close

KARD News

KARD Events

9/30 08:30

Kardigan Appoints Kristin Reinke to Board of Directors

Kardigan (KARD) announced the appointment of Kristin Reinke to its Board of Directors, where she will serve as chair of the Audit Committee. As part of the Board's public company evolution, Doug Giordano will be stepping down from the Board. Reinke is currently vice president of finance at Google (GOOG), where she leads the application of AI to modernize and scale the company's finance organization.

8/11 07:30

Kardigan Cash and Investments Reach $660.7 Million

Cash, cash equivalents and investments were $660.7M as of June 30, 2026, compared to $335.5M as of December 31, 2025. "Our IPO has positioned Kardigan to advance a portfolio of late-stage cardiovascular programs to address diseases where patients urgently need better treatment options," said Tassos Gianakakos, co-founder, chief executive officer, and chair of the board of Kardigan. "As we initiate our Phase 3 KINSHIP-DCM trial, dose patients in our Phase 2b KARDINAL-ASH trial, and continue enrollment in our Phase 2b KATALYST-AV trial, we are entering a pivotal period with multiple clinical milestones expected over the next 12 months that will shape the registrational path for each of our medicines."

7/13 13:00

SK Hynix Raises $26.5B in Historic U.S. IPO

With a quiet IPO calendar last week, SK Hynix took the spotlight, opening above its pricing in the largest U.S. listing by a foreign company in history, raising approximately $26.5B.LATEST IPOS AND DIRECT LISTINGS:SK Hynixopened on July 10 at $170 after pricing its U.S. IPO at $149 per ADR, or American Depositary Receipt. "Beyond raising capital, this listing is expected to serve as a turning point for SK Hynix, enabling the company to strengthen its ties with the next-generation computing ecosystem, unlock new business opportunities and deepen strategic partnerships down the road," the company stated. SK Hynix, headquartered in Korea, is a semiconductor supplier offering Dynamic Random Access Memory chips, or DRAM, and flash memory chips, or NAND flash, for a wide range of customers globally.RECENT SPAC IPOS:Samos Energy Acquisitionopened on July 10 at $9.96. Cantor Fitzgerald is acting as the sole book running manager for the proposed offering.Freedom Metals Acquisitionopened on July 8 at $9.96. The blank check company may pursue an acquisition opportunity in any industry, sector or geographic region, but the company's primary focus will be on target businesses in the mining and critical minerals industry.Bleichroeder Acquisition IIIopened on July 7 at $10.04. Cohen & Company Capital Markets is acting as lead book-running manager for the offering.PERFORMANCE:As of about 12:30 pm ET on Monday, July 13, SK Hynix was trading at $154.07.RECENT IPOS TO WATCH:Kardiganand Deep Fissionare seeing coverage roll out as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include Jersey Mike's Subs, Inspire Brands, and Tarsier Pharma.Clickto see upcoming IPO calendar on TipRanks.Jersey Mike's Subs has filed an initial public offering of shares of Class A common stock. The company has applied to list its shares of Class A common stock on the New York Stock Exchange under the trading symbol "JMKE." Morgan Stanley, Jefferies, and J.P. Morgan are acting as global coordinators and joint bookrunning managers for the offering. Barclays and Guggenheim Securities are acting as co-global coordinators and joint bookrunning managers. BofA Securities, Goldman Sachs, Evercore ISI, UBS Investment Bank, Baird, Wells Fargo Securities, William Blair, RBC Capital Markets, Deutsche Bank Securities, Wolfe Nomura Alliance, Piper Sandler, Raymond James, Stifel, TD Securities, BTIG, Mizuho, Societe Generale, and Truist Securities are acting as joint bookrunning managers. Blackstone Capital Markets, Loop Capital Markets, and Tigress Financial Partners are acting as co-managers.Inspire Brands announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Inspire Brands expects to use the net proceeds of the proposed offering to repay outstanding indebtedness under its existing term loan facility and pay offering fees and expenses.Tarsier Pharma Ltd. filed for an initial public offering of its ordinary shares and applied to list its ordinary shares on the NYSE American under the symbol "TARX". The prospectus stated: "Tarsier Pharma is developing TRS01 and TRS02, novel product candidates based on dazdotuftide, a new molecule with a new mechanism of action for uveitis and uveitic glaucoma. We are attempting to address a significant, underserved market opportunity and have engaged closely with the FDA on our clinical development strategy, including a Special Protocol Assessment agreement for our planned pivotal trial... Although we are still early in this journey, I believe we have the technology, the team, the discipline, and the persistence required to build an enduring company.""Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading